Please Wait.....
Report
Europe Travel Vaccine Market - Industry Trends and Forecast to 2033
Market Report I 2024-03-01 I 298 Pages I Data Bridge Market Research
Europe travel vaccine market is expected to reach USD 3,528,168.83 thousand by 2032 from USD 1,590,722.71 thousand in 2023, growing at a substantial CAGR of 9.4% in the forecast period of 2024 to 2032.
Market Segmentation:
Europe travel vaccines market, By Composition (Combination Vaccines and Mono Vaccines), Type (Inactivated Vaccines, Subunit, Recombinant, Polysaccharide and Conjugate Vaccines, Live-Attenuated Vaccines, Toxoid Vaccines, DNA Vaccines, and Viral Vector Vaccines), Category (Recommended Vaccine, Routine Vaccine and Required Vaccine), Disease (Typhoid, Hepatitis, Cholera, Varicella, Influenza, Japanese Encephalitis, Meningococcal Meningitis, Yellow Fever, Rabies, DPT, Measles and Mumps, Tick-Borne Encephalitis, Malaria, Covid-19, Polio and Others), Route of Administration (Injectable and Oral), Gender (Male and Female), Patient Type (Adult, Pediatric and Geriatric), Age Group (20-50 Years, Less than 20 Years and Above 50 Years), Distribution Channel (B2B and B2C), Countries (Germany, U.K., France, Italy, Netherlands, Spain, Russia, Switzerland, Poland, Norway, Hungary, Austria, Ireland, Lithuania, and Rest of Europe) - Industry Trends and Forecast to 2032
Some of the major factors contributing to the growth of the Europe travel vaccines market are:
Driver
- Rising incidence of infectious diseases
Restraint
- High cost of travel vaccines
Opportunity
- Advancements in vaccine technology
Market Players
Some major companies dealing in the Europe travel vaccines market are:
- GSK plc.
- Bavarian Nordic
- Pfizer Inc.
- Abbott
- CSL
- AstraZeneca
- Sanofi
- Merck & Co., Inc.
- Valneva SE
- Johnson & Johnson Services Inc.
- Dynavax Technologies.
TABLE OF CONTENTS
1 INTRODUCTION 50
1.1 OBJECTIVES OF THE STUDY 50
1.2 MARKET DEFINITION 50
1.3 OVERVIEW OF EUROPE TRAVEL VACCINES MARKET 50
1.4 LIMITATIONS 52
1.5 MARKETS COVERED 52
2 MARKET SEGMENTATION 56
2.1 MARKETS COVERED 56
2.2 GEOGRAPHICAL SCOPE 57
2.3 YEARS CONSIDERED FOR THE STUDY 58
2.4 CURRENCY AND PRICING 58
2.5 DBMR TRIPOD DATA VALIDATION MODEL 59
2.6 MULTIVARIATE MODELLING 62
2.7 PRODUCT TYPE LIFELINE CURVE 62
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 63
2.9 DBMR MARKET POSITION GRID 64
2.10 MARKET APPLICATION COVERAGE GRID 65
2.11 VENDOR SHARE ANALYSIS 66
2.12 SECONDARY SOURCES 67
2.13 ASSUMPTIONS 67
3 EXECUTIVE SUMMARY 68
4 PREMIUM INSIGHTS 71
4.1 PESTEL ANALYSIS 72
4.2 PORTER'S FIVE FORCES 73
4.3 PIPELINE ANALYSIS 74
5 MARKET OVERVIEW 78
5.1 DRIVERS 80
5.1.1 RISING INCIDENCE OF INFECTIOUS DISEASES 80
5.1.2 INCREASING TRAVEL AND TOURISM 82
5.1.3 GOVERNMENT REGULATIONS AND RECOMMENDATIONS REGARDING VACCINATION 83
5.1.4 EXPANSION OF TRAVEL MEDICINE CLINICS 83
5.2 RESTRAINTS 84
5.2.1 HIGH COST OF TRAVEL VACCINES 84
5.2.2 REGULATORY HURDLES FOR APPROVAL 85
5.3 OPPORTUNITIES 85
5.3.1 ADVANCEMENTS IN VACCINE TECHNOLOGY 85
5.3.2 GROWING AWARENESS REGARDING VACCINES 86
5.3.3 INTEGRATION OF DIGITAL HEALTH SOLUTIONS 86
5.4 CHALLENGES 87
5.4.1 COLD CHAIN REQUIREMENTS FOR STORAGE 87
5.4.2 VACCINE HESITANCY AND MISINFORMATION 88
6 EUROPE TRAVEL VACCINE MARKET, BY COMPOSITION 89
6.1 OVERVIEW 90
6.2 COMBINATION VACCINES 93
6.3 MONO VACCINES 93
7 EUROPE TRAVEL VACCINE MARKET, BY TYPE 94
7.1 OVERVIEW 95
7.2 INACTIVATED VACCINES 98
7.2.1 HEPATITIS A 99
7.2.2 INFLUENZA 99
7.2.3 RABIES 99
7.2.4 TICK-BORNE ENCEPHALITIS 99
7.2.5 JAPANESE ENCEPHALITIS 99
7.2.6 POLIO 100
7.3 SUBUNIT, RECOMBINANT, POLYSACCHARIDE AND CONJUGATE VACCINES 100
7.3.1 HEPATITIS B 101
7.3.2 MENINGOCOCCAL 101
7.3.3 MALARIA 101
7.3.4 COVID-19 101
7.4 LIVE-ATTENUATED VACCINES 102
7.4.1 TYPHOID 103
7.4.2 CHOLERA 103
7.4.3 YELLOW FEVER 103
7.4.4 MEASLES 103
7.4.5 MUMPS 104
7.4.6 RUBELLA 104
7.4.7 VARICELLA 104
7.4.8 OTHERS 104
7.5 TOXOID VACCINES 104
7.5.1 DIPHTHERIA 105
7.5.2 TETANUS 105
7.6 DNA VACCINES 105
7.7 VIRAL VECTOR VACCINES 106
8 EUROPE TRAVEL VACCINE MARKET, BY CATEGORY 107
8.1 OVERVIEW 108
8.2 RECOMMENDED VACCINE 111
8.2.1 TYPHOID FEVER VACCINES 112
8.2.2 HEPATITIS A 112
8.2.3 CHOLERA 112
8.2.4 RABIES 112
8.2.5 TICK-BORNE ENCEPHALITIS 112
8.2.6 JAPANESE ENCEPHALITIS 112
8.2.7 MALARIA 112
8.2.8 OTHERS 112
8.3 ROUTINE VACCINE 113
8.3.1 HEPATITIS B 114
8.3.2 INFLUENZA VACCINES 114
8.3.3 PNEUMOCOCCAL 114
8.3.4 DIPHTHERIA 114
8.3.5 TETANUS 114
8.3.6 MEASLES 114
8.3.7 MUMPS 114
8.3.8 RUBELLA 114
8.3.9 PERTUSSIS 114
8.3.10 OTHERS 115
8.4 REQUIRED VACCINE 115
8.4.1 YELLOW FEVER 116
8.4.2 MENINGOCOCCAL 116
8.4.3 POLIO VACCINES 116
9 EUROPE TRAVEL VACCINE MARKET, BY DISEASE 117
9.1 OVERVIEW 118
9.2 TYPHOID 122
9.3 HEPATITIS 122
9.3.1 HEPATITIS A 123
9.3.2 HEPATITIS B 123
9.4 CHOLERA 123
9.5 VARICELLA 124
9.6 INFLUENZA 124
9.7 JAPANESE ENCEPHALITIS 125
9.8 MENINGOCOCCAL MENINGITIS 125
9.9 YELLOW FEVER 126
9.10 RABIES 126
9.11 DPT 127
9.12 MEASLES AND MUMPS 127
9.13 TICK-BORNE ENCEPHALITIS 128
9.14 MALARIA 128
9.15 COVID-19 129
9.16 POLIO 129
9.17 OTHERS 130
10 EUROPE TRAVEL VACCINE MARKET, BY ROUTE OF ADMINISTRATION 131
10.1 OVERVIEW 132
10.2 INJECTABLE 135
10.2.1 INTRAMUSCULAR 136
10.2.2 SUBCUTANEOUS 136
10.2.3 OTHERS 136
10.3 ORAL 136
11 EUROPE TRAVEL VACCINE MARKET, BY GENDER 137
11.1 OVERVIEW 138
11.2 MALE 141
11.3 FEMALE 141
12 EUROPE TRAVEL VACCINE MARKET, BY PATIENT TYPE 142
12.1 OVERVIEW 143
12.2 ADULT 146
12.3 PEDIATRIC 146
12.4 GERIATRIC 147
13 EUROPE TRAVEL VACCINE MARKET, BY AGE GROUP 148
13.1 OVERVIEW 149
13.2 20-50 YEARS 152
13.3 LESS THAN 20 YEARS 153
13.4 ABOVE 50 YEARS 154
14 EUROPE TRAVEL VACCINE MARKET, BY DISTRIBUTION CHANNEL 155
14.1 OVERVIEW 156
14.2 B2B 159
14.3 B2C 159
15 EUROPE TRAVEL VACCINE MARKET, BY REGION 160
15.1 EUROPE 163
15.1.1 GERMANY 171
15.1.2 U.K. 177
15.1.3 FRANCE 183
15.1.4 RUSSIA 189
15.1.5 ITALY 195
15.1.6 SPAIN 201
15.1.7 POLAND 207
15.1.8 NETHERLANDS 213
15.1.9 SWITZERLAND 219
15.1.10 HUNGARY 225
15.1.11 AUSTRIA 230
15.1.12 IRELAND 236
15.1.13 NORWAY 241
15.1.14 LITHUANIA 246
15.1.15 REST OF EUROPE 251
16 EUROPE TRAVEL VACCINE MARKET: COMPANY LANDSCAPE 252
16.1 COMPANY SHARE ANALYSIS: EUROPE 252
17 SWOT ANALYSIS 253
18 COMPANY PROFILE 254
18.1 PFIZER INC. 254
18.1.1 COMPANY SNAPSHOT 254
18.1.2 REVENUE ANALYSIS 254
18.1.3 COMPANY SHARE ANALYSIS 255
18.1.4 PRODUCT PORTFOLIO 255
18.1.5 RECENT DEVELOPMENT 256
18.2 SANOFI 257
18.2.1 COMPANY SNAPSHOT 257
18.2.2 REVENUE ANALYSIS 257
18.2.3 COMPANY SHARE ANALYSIS 258
18.2.4 PRODUCT PORTFOLIO 258
18.2.5 RECENT DEVELOPMENT 262
18.3 JOHNSON & JOHNSON SERVICES INC. 263
18.3.1 COMPANY SNAPSHOT 263
18.3.2 REVENUE ANALYSIS 263
18.3.3 COMPANY SHARE ANALYSIS 264
18.3.4 PRODUCT PORTFOLIO 264
18.3.5 RECENT DEVELOPMENTS 265
18.4 GSK PLC. 266
18.4.1 COMPANY SNAPSHOT 266
18.4.2 REVENUE ANALYSIS 266
18.4.3 COMPANY SHARE ANALYSIS 267
18.4.4 PRODUCT PORTFOLIO 267
18.4.5 RECENT DEVELOPMENT 272
18.5 MERCK & CO., INC. 274
18.5.1 COMPANY SNAPSHOT 274
18.5.2 REVENUE ANALYSIS 274
18.5.3 COMPANY SHARE ANALYSIS 275
18.5.4 PRODUCT PORTFOLIO 275
18.5.5 RECENT DEVELOPMENT 277
18.6 ABBOTT 278
18.6.1 COMPANY SNAPSHOT 278
18.6.2 REVENUE ANALYSIS 278
18.6.3 PRODUCT PORTFOLIO 279
18.6.4 RECENT DEVELOPMENT 280
18.7 ASTRAZENECA 281
18.7.1 COMPANY SNAPSHOT 281
18.7.2 REVENUE ANALYSIS 281
18.7.3 PRODUCT PORTFOLIO 282
18.7.4 RECENT DEVELOPMENT 282
18.8 BAVARIAN NORDIC 284
18.8.1 COMPANY SNAPSHOT 284
18.8.2 REVENUE ANALYSIS 284
18.8.3 PRODUCT PORTFOLIO 285
18.8.4 RECENT DEVELOPMENT 285
18.9 CSL 287
18.9.1 COMPANY SNAPSHOT 287
18.9.2 REVENUE ANALYSIS 287
18.9.3 PRODUCT PORTFOLIO 288
18.9.4 RECENT DEVELOPMENT 289
18.10 DYNAVAX TECHNOLOGIES. 290
18.10.1 COMPANY SNAPSHOT 290
18.10.2 REVENUE ANALYSIS 290
18.10.3 PRODUCT PORTFOLIO 291
18.10.4 RECENT DEVELOPMENTS 291
18.11 VALNEVA SE 292
18.11.1 COMPANY SNAPSHOT 292
18.11.2 REVENUE ANALYSIS 292
18.11.3 PRODUCT PORTFOLIO 293
18.11.4 RECENT DEVELOPMENT 293
19 QUESTIONNAIRE 294
20 RELATED REPORTS 298
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security